MEET

ANODYNE

MEET POLYSTAT

WHO ARE WE 

Anodyne is a preclinical-stage biotech company developing differentiated, transdermal forms of
high-value drugs.

 

The company’s patent-pending, porous microneedle technology provides the first practical and cost-effective platform, Hero Patch, to deliver clinically meaningful doses of

macromolecules (such as monoclonal antibodies) or small molecules (such as ibuprofen) for fast and sustained delivery.

We pride ourselves on providing a painless experience for all of those involved in the production, delivery, and consumption of medicines.

OUR VISION

At Anodyne Nanotech, we believe that the delivery of necessary medication should not and will not be a painful process. For anyone involved. For hundreds of years, needles and syringes have been used to deliver medicine, and innovation is long overdue.

The Hero Patch is the first platform capable of efficiently delivering large enough quantities of medicine to begin replacing antiquated and cumbersome injections.


Together, we will redefine drug delivery.

THE TEAM

 
THE FOUNDERS

Jake Lombardo

CO-FOUNDER  AND CEO

  • Grey LinkedIn Icon

KONSTANTINOS

TZORTZAKIS

CO-FOUNDER AND CBO

  • Grey LinkedIn Icon

HOJAT REZAEi
nejad

CO-FOUNDER AND CTO

  • Grey LinkedIn Icon

Read more


Jake has a unique combination of biomedical engineering experience and entrepreneurial acumen. He holds a B.S. of Biomedical Engineering from Union College and an M.Sc. of Innovation and Management from Tufts University. He couples this with leadership qualities developed over a lifetime of team sports to help set the direction of Anodyne.





Read more


Konstantinos is an engineer turned entrepreneur. He holds a Diploma in Electrical and Computer Engineering from National Technical University of Athens and an M.Sc. in Innovation and Management from Tufts University, Boston, USA. Konstantinos has engineering and management expertise coupled with exposure in the US and Greece, making the alignment of interdisciplinary teams second nature.





Read more


Jake has a unique combination of biomedical engineering experience and entrepreneurial acumen. He holds a B.S. of Biomedical Engineering from Union College and an M.Sc. of Innovation and Management from Tufts University. He couples this with leadership qualities developed over a lifetime of team sports to help set the direction of Anodyne.





BOARD OF ADVISORS

Read more


Jake has a unique combination of biomedical engineering experience and entrepreneurial acumen. He holds a B.S. of Biomedical Engineering from Union College and an M.Sc. of Innovation and Management from Tufts University. He couples this with leadership qualities developed over a lifetime of team sports to help set the direction of Anodyne.





Read more


Dr. Sameer Sonkusale is the Principal Investigator of the microneedle technology and a Professor of Electrical Engineering at Tufts University. Prior to his time at Tufts, he graduated with his Ph.D. in Electrical Engineering from the University of Pensylvania. Dr. Sonkusale is a respected inventor with a portfolio of innovation, as well as Director and Principal Investigator of Nanolab. He is frequently recognized for his innovative projects, including 3D printed pills to sample the gut microbiome and Smart Threads.





Read more


Joseph Gentile was Vice President and the General Manager at Becton Dickinson Biosciences for over a decade. Over that period, he saw this business grow to over $1.2 Billion in revenue. He is a graduate of Boston University where he earned his M.Eng in Biomedical Engineering and his MBA. He is now a successful board member, strategic advisor and investor for healthcare companies.





SAMEER SONKUSALE

SCIENTIFIC ADVISOR

  • Grey LinkedIn Icon
  • Grey LinkedIn Icon
  • Grey LinkedIn Icon

JOSEPH GENTILE

 

SENIOR ADVISOR

MICHAEL SINGER

SENIOR ADVISOR

Redefining drug delivery

GET CONNECTED

Boston

Massachusetts, USA